No mention here of the FDA’s dairy policy, but I don’t know why questions about raw milk shouldn’t be raised in a conference like this.
“A conference co-sponsored by the George Washington University School of Public Health and Health Services and the Union of Concerned Scientists
As Congress prepares to debate and reauthorize the laws that govern how drugs and medical devices are evaluated, the Food and Drug Administration (FDA) stands at a crossroads. The decisions of Congress regarding the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA) will affect the agency’s ability to address existing and emerging challenges such as new medical technology, prescription drug and device efficacy and safety concerns, and budget limitations. Continue reading